| Literature DB >> 24885031 |
Jige Guo, Yue Wang, Jihong Zhu, Jie Cao, Zili Chen, Zhijun Li, Ximing Qian1.
Abstract
OBJECTIVES: Aortic arch replacement is associated with increased mortality and morbidity especially in acute type-A aortic dissection. Although hypothermic circulatory arrest with selective antegrade cerebral perfusion has been widely used because of its excellent cerebral protection, its optimal perfusion characteristics are unknown. The present study investigates clinical results obtained after perfusion method modification and temperature management during cardiopulmonary bypass (CPB).Entities:
Mesh:
Year: 2014 PMID: 24885031 PMCID: PMC4068358 DOI: 10.1186/1749-8090-9-94
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Demographics for 16 patients undergoing aortic arch replacement
| Age (years ± SD) | 50 ± 14.1 |
| Male | 12 (75.0%) |
| Female | 4 (25.0%) |
| Body weight (Kg ± SD) | 70.6 ± 10.6 |
| Marfan syndrome | 2 (12.5%) |
| Hypertension | 8 (50.0%) |
| Smoking | 6 (37.5%) |
| History of cerebrovascular accident | 1 (6.3%) |
| Preoperative neurologic dysfuction | 1 (6.3%) |
| Preoperative ventilation | 2 (12.5%) |
Figure 1Cardiopulmonary bypass diagram.
Operative data and surgical procedures for 16 patients undergoing aortic arch replacement
| Cardiopulmonary bypass time (min ± SD) | 201 ± 53 |
| Myocardial ischemic time (min ± SD) | 140 ± 42 |
| SCP time (min ± SD) | 80 ± 16 |
| Lower body circulatory arrest time (min ± SD) | 20 ± 13 |
| Nasopharyngeal temperature at SCP (°C ± SD) | 31.1 ± 1.5 |
| Rectal temperature at SCP (°C ± SD) | 32.5 ± 1.4 |
| SCP flowrate (ml/kg/min ± SD) | 27.9 ± 5.3 |
| Femoral artery perfusion flowrate (ml/kg/min ± SD) | 33.8 ± 4.9 |
| Hemiarch replacement (n/%) | 5 (31.2%) |
| Total arch replacement (n/%) | 11 (68.8%) |
| Aortic root procedure | |
| Bentall operation (n/%) | 4 (25.0%) |
| Aortic valvuloplasty | 7 (43.8%) |
Operative outcome of 16 patients undergoing aortic arch replacement
| Chest tube drainage (ml/24 h ± SD) | 770 ± 626 |
| Intraop and postop 12 h RBC transfusion (unites ± SD) | 4.9 ± 2.8 |
| Intraop and postop 12 h plasma transfusion (ml ± SD) | 1256 ± 430 |
| Length of ICU stay (days ± SD) | 7.5 ± 7.9 |
| Ventilation > 72 hours (n/%) | 5 (31.2%) |
| Tracheostomy (n/%) | 2 (12.5%) |
| Renal dysfunction (n/%) | 3 (18.8%) |
| Hemodiafiltration (n/%) | 2 (12.5%) |
| Re-exploration for bleeding (n/%) | 1 (6.3%) |
| Temporary neurologic deficit (n/%) | 2 (12.5%) |
| Permanent neurologic deficit (n/%) | 1 (6.3%) |
| 30-days mortality (n/%) | 0 (0%) |